Irene Agodoa, MD

Articles by Irene Agodoa, MD

Irene Agodoa, MD, on Addressing GVHD Risks in Treating Hematologic Malignancies

August 26th 2022

The senior vice president and head of medical affairs at Orca Bio discussed how Orca-T has been developed to lower the risk of graft-versus-host disease.

Irene Agodoa, MD, on Assessing Orca-T for Safer Cell Therapy in Hematologic Malignancies

ByIrene Agodoa, MD

August 20th 2022

The senior vice president and head of medical affairs at Orca Bio discussed the initiation of the Precision-T phase 3 trial.

Latest Updated Articles

Irene Agodoa, MD, on Addressing GVHD Risks in Treating Hematologic Malignancies
August 26th 2022